Topic: GI ASCO 2012, San Francisco
The purpose of the Gastrointestinal (GI) Cancer Symposium is to bring together multiple disciples including The American Gastroenterological Association (AGA) Institute, http://www.gastro.org/, The Society of Surgical Oncology, http://www.surgonc.org/, The American Society of Clinical Oncology, http://www.asco.org/, and The American Society for Radiation Oncology https://www.astro.org/.
The GI ASCO multidiscipline disciples gather in order to solve problems or redefine solutions and problems by drawing on the vast knowledge and experience offered by the experts of each specialty. The three-day meeting presented the newest strategies in prevention, screening and the treatment of gastrointestinal cancers. In addition to the abstract presentations this symposium offers educational sessions for each type of GI cancer including the disease of most significance to us, the hepatobiliary tract cancer.
I would like to extend my sincere gratitude to Tim and Lesley for volunteering their time and energy to our cause. Without their selfless engagement representation at this conference would not have come about. Helping others in need is such an important part of the American way. It grants us the opportunity to change lives, including our own. Amongst other benefits it can also provide us with a coping mechanism against trauma experienced or the frustration encountered when touched by this cancer. Thank you, Tim and Lesley.
This is Lesley’s second engagement. For those who don’t know, Lesley is a two year survivor of CC. This conference provides her with the unique opportunity to engage in conversations, based on her own experience, with physicians and researchers alike.
Tim, who lost his dear Mom to this disease a few years ago, has vast experience in the area of research and made good use of it by identifying lectures and poster board presentation relevant to the disease of Cholangiocarcinoma. Tim will post his personal commentary on the discussion board, including the abstracts within the next few days.
Your donations to the The Cholangiocarcinoma Foundation have allowed us to contribute to research studies of the disease of Cholanngiocarcinoma via The Conquer Cancer Foundation, a branch of the ASCO organization.
http://www.conquercancerfoundation.org/ … tor+Award.
One of the two young investigator grants had been awarded to Dr. Flavio G. Rocha, who evaluated the significance of occurrence of CEACAM6 expression in biliary tract carcinoma.
Tim will include this particular presentation in his upcoming posting. Dr. Rochas study in its entirety will be posted on this board at a later time.
As one of two advocates bringing the patient perspective to the development of Phase II/III in the NCI sponsored North American Hepatobiliary Task Force, my attendance
also was required at one of the two annual Face to Face meeting. Although we participate in a monthly phone conference nothing equals the special touch of interacting person to person.
For those of you participating in a clinical trial there is a possibility that my input in the development of this trial allowed me to bring your voice to the discussion.
Hugs to all,